Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-02-05
1989-10-03
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 544367, 548229, 548231, 548232, A61K 3142, A61K 31495
Patent
active
048717550
ABSTRACT:
The oxazolidines of the formula ##STR1## wherein n signifies the number 1 or 2.
REFERENCES:
patent: 4156789 (1979-05-01), Hauck et al.
Ariens, E. S., Drug Design, Academic Press, N.Y. (1971) pp. 74, 92.
Burger Alfred, Medicinal Chemistry III, Wiley Interscience (1970) p. 71.
Derwent Abstract 15538.
Derwent Abstract 18335.
Derwent Abstract 20925.
Derwent Abstract 22707.
Derwent Abstract 26138.
Derwent Abstract 36501.
Derwent Abstract 36802.
Derwent Abstract 33331e.
Derwent Abstract 19557r.
Derwent Abstract 35794r.
Derwent Abstract 74007r.
Derwent Abstract 84541r.
Derwent Abstract 69076s.
Derwent Abstract 75837s.
Derwent Abstract 77515s.
Derwent Abstract 1836t.
Derwent Abstract 48801u.
Derwent Abstract 49596v.
Derwent Abstract 54111v.
Derwent Abstract 30464w.
Derwent Abstract 29125v.
Alig Leo
Muller Marcel
Boxer Matthew
Hoffmann-La Roche Inc.
Leon Bernard S.
Saxe Jon S.
Shen Cecilia
LandOfFree
Method for treating diabetes obesity and conditions characterize does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating diabetes obesity and conditions characterize, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating diabetes obesity and conditions characterize will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664626